This is the authors' abstract. We don't add key points for this paper.
Resveratrol, a stilbene in soybeans, grapes, pines, legumes, pomegranates, and peanuts, exhibits varied bioactivity. It is antioxidant, provides photoprotection, demonstrates anti-inflammatory, antipyretic, cardioprotective, antiestrogenic, anticancer, and antimicrobial effects, while also inhibit platelet aggregation. This study reports design, synthesis, and biological activity of its 3 (d1–d3) new diazo derivatives using bioisoster strategy. In DPPH test, d1 showed excellent antioxidant activity (IC50 = 19.95 µg/mL), close to resveratrol (IC50 = 21.23 µg/mL). Anticancer properties, estimated by brine shrimp lethality test (BSLT), showed appreciable LC50 value of 70.4 μg/mL for d3, again near to resveratrol (LC50 = 73.4 μg/mL). In MTT cytotoxicity test, d2 recorded LC50 value of 30.7 μg/mL, considerably better than resveratrol (LC50 = 72.3 µg/mL). In antimicrobial tests, d3 appeared very effective against eight bacterial and two fungal pathogenic strains. These findings candidate the derivatives as suitable ingredients for application in pharmaceutical and/or food industries after necessary supplementary studies.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Yousefi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: